Published in J Pediatr on January 01, 1990
An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med (2013) 1.84
Idiopathic pulmonary fibrosis in infants: good prognosis with conservative management. Arch Dis Child (2000) 1.39
Interstitial lung diseases in children. Orphanet J Rare Dis (2010) 1.28
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Management of asthma: a consensus statement. Arch Dis Child (1989) 7.04
Prediction of mortality in patients with cystic fibrosis. N Engl J Med (1992) 5.46
The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70
A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol (1988) 4.41
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35
Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr (1997) 3.38
Bronchial reactivity in cystic fibrosis. Pediatrics (1978) 2.70
A sensory neuron-specific, proton-gated ion channel. Proc Natl Acad Sci U S A (1998) 2.61
Standards of pulmonary function in children. Am Rev Respir Dis (1969) 2.56
Sustained-release theophylline for childhood asthma: evidence for circadian variation of theophylline pharmacokinetics. J Pediatr (1981) 2.41
Pulmonary function abnormalities in symptom-free children after bronchiolitis. Pediatrics (1977) 2.32
Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr (1990) 2.28
Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med (1984) 2.22
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer. Gene Ther (1999) 2.17
Does cholesterol screening result in negative labeling effects? Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project. Arch Intern Med (1991) 2.14
Comparison of community based service with hospital based service for people with acute, severe psychiatric illness. BMJ (1993) 2.14
An SH3 binding region in the epithelial Na+ channel (alpha rENaC) mediates its localization at the apical membrane. EMBO J (1994) 2.10
High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet (1987) 2.05
Five- to seven-year course of pulmonary function in cystic fibrosis. Am Rev Respir Dis (1976) 2.03
Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. Pediatrics (1981) 2.00
Ultrastructure of airways in children with asthma. Histopathology (1978) 1.97
Effects of anesthesia and paralysis on diaphragmatic mechanics in man. Anesthesiology (1974) 1.95
Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Annu Rev Physiol (1999) 1.93
HSC clinical trials controversy continues. Hospital for Sick Children. Nat Med (1999) 1.78
Hepatic abscess and cystic fibrosis. Postgrad Med J (1988) 1.77
Role of conventional physiotherapy in cystic fibrosis. J Pediatr (1988) 1.75
Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70
DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet (1989) 1.66
Diabetes mellitus in patients with cystic fibrosis: effect on survival. Pediatrics (1990) 1.65
Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr (1982) 1.64
Increased incidence of bronchial reactivity in children with a history of bronchiolitis. J Pediatr (1981) 1.62
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60
Clinical and physiological assessment of asthmatic children treated with beclomethasone dipropionate. J Allergy Clin Immunol (1976) 1.59
Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol (1998) 1.59
Nam1p, a protein involved in RNA processing and translation, is coupled to transcription through an interaction with yeast mitochondrial RNA polymerase. J Biol Chem (2000) 1.58
Transit time analysis of the forced expiratory vital capacity in cystic fibrosis. Am Rev Respir Dis (1976) 1.58
Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr (1995) 1.56
Effects of respiration on cardiac performance. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.55
Severe acute asthma in a pediatric intensive care unit: six years' experience. Pediatrics (1989) 1.54
Passive respiratory mechanics in newborns and children. Am Rev Respir Dis (1984) 1.53
Volume of isoflow. A new test in detection of mild abnormalities of lung mechanics. Am Rev Respir Dis (1974) 1.53
Performance of the Reflotron in Massachusetts' Model System for Blood Cholesterol Screening Program. Am J Public Health (1992) 1.53
Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant (2001) 1.53
Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease. Am J Med (1985) 1.52
Pulmonary function in children with asthma at acute attack and symptom-free status. Am Rev Respir Dis (1969) 1.52
The approach to chronic cough in childhood. Ann Allergy (1988) 1.51
Mucociliary tracheal transport rates in man. J Appl Physiol (1975) 1.50
Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project. JAMA (1991) 1.48
Lung function in children following repair of tracheoesophageal fistula. J Pediatr (1979) 1.46
Airway closure in children. J Appl Physiol (1972) 1.45
Hypoalbuminemia at initial examination in patients with cystic fibrosis. J Pediatr (1989) 1.45
Nitric oxide inhalation for paraquat-induced lung injury. J Toxicol Clin Toxicol (1998) 1.45
Childhood asthma: a rational approach to treatment. Ann Allergy (1990) 1.44
Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest (1992) 1.44
Lung disease in mice with cystic fibrosis. J Clin Invest (1997) 1.44
Menstrual asthma: use of a gonadotropin-releasing hormone analogue for the treatment of cyclic aggravation of bronchial asthma. Fertil Steril (1994) 1.43
The effect of single-dose and continuous skeletal muscle paralysis on respiratory system compliance in paediatric intensive care patients. Intensive Care Med (1996) 1.43
Spacers in childhood asthma--is there one for all occasions? Ann Allergy (1990) 1.43
Trampoline use as physiotherapy for cystic fibrosis patients. Pediatr Pulmonol (2005) 1.42
Maximal expiratory flows generated by rapid chest compression following end-inspiratory occlusion or expiratory clamping in young children. Eur Respir J (1995) 1.41
Transcutaneous monitoring of oxygenation: what is normal? J Pediatr (1986) 1.37
Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus. J Pediatr (1989) 1.37
Changes in ventilation and chest wall mechanics during sleep in normal adolescents. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.36
Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J Appl Physiol (1985) (1987) 1.36
The open lung during small tidal volume ventilation: concepts of recruitment and "optimal" positive end-expiratory pressure. Crit Care Med (1999) 1.35
Spacing devices and metered-dose inhalers in childhood asthma. J Pediatr (1985) 1.35
Sodium cromoglycate-induced changes in the dose-response curve of inhaled methacholine and histamine in asthmatic children. Am Rev Respir Dis (1979) 1.35
Ventilation by high-frequency oscillation in humans. Anesth Analg (1980) 1.35
Intermittent positive pressure respiration as a treatment in severe respiratory distress syndrome. Arch Dis Child (1965) 1.34
Pregnancy and cystic fibrosis. Obstet Gynecol (1991) 1.33
The response to exercise in normal and asthmatic children. J Pediatr (1978) 1.32
Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa. Pediatr Pulmonol (1989) 1.31
Retinal hemorrhage at high altitude. N Engl J Med (1970) 1.31
High-versus low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics (1989) 1.30
Pulmonary function in infants and children following the acute neonatal respiratory distress syndrome. Bull Physiopathol Respir (Nancy) (1974) 1.30
Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr (1993) 1.30
Early detection of pulmonary function abnormalities in cystic fibrosis. Pediatrics (1972) 1.29
Ventilation by high-frequency oscillation. J Appl Physiol Respir Environ Exerc Physiol (1980) 1.29
Acute asthma: observations regarding the management of a pediatric emergency room. Pediatrics (1989) 1.27
Control of acute mountain sickness. Aerosp Med (1971) 1.27
Comparison of conventional and high-frequency ventilation: oxygenation and lung pathology. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.26
Ventilatory muscle endurance training in normal subjects and patients with cystic fibrosis. Am Rev Respir Dis (1977) 1.26
Alpha 1 antitrypsin deficiency in association with both cirrhosis and chronic obstructive lung disease in two sibs. Am J Med (1973) 1.26
Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am Rev Respir Dis (1984) 1.26
Relative sensitivity of methods for measuring airway resistance in asthmatic children. Ann Allergy (1969) 1.25
Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma. J Pediatr (1985) 1.25